Verrica Pharmaceuticals Inc. ( VRCA) - Key Metrics
VRCA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.48 | -$0.76 | -$0.43 | -$0.43 |
| 2025Q3 | $1.51 | -$0.03 | $1.02 | $1.02 |
| 2025Q2 | $1.34 | $0.02 | -$1.06 | -$1.06 |
| 2025Q1 | $0.36 | -$1.03 | -$1.34 | -$1.34 |
VRCA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.74 |
| 2025Q3 | ? | -37.32 |
| 2025Q2 | ? | 61.63 |
| 2025Q1 | ? | -1.08 |
VRCA
Price: $5.63
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 337100
Market Capitalization: 64.3 million